摘要
目的 :比较 5 FU/LV、L OHP +5 FU/LV及CPT 11+5 FU/LV治疗晚期大肠癌的疗效和毒副反应。方法 :采用三种方案对 6 5例患者进行研究 ,3周为一个疗程。 5 FU/LV方案为LV 2 0 0mg/d ,iv 2小时 ,第 1~ 5天 ;5 FU5 0 0mg/d ,iv第 1~ 5天 ;L OHP +5 FU/LV方案为L OHP 130mg/m2 iv第 1天 ,5 FU/LV用法同上 ;CPT 11+5 FU/LV方案为CPT 11180mg/m2 30分钟第 1天 ,5 FU/LV用法同上。至少化疗 2个疗程后进行评价。结果 :三种方案总体疗效分别为 13.33%、2 1.2 1%、11.76 % ;总体恶心、呕吐发生率分别为 4 0 .0 0 %、39.39%、17.6 5 % ;腹泻发生率分别为 13.33%、6 .0 6 %、2 9.4 1% ;骨髓抑制发生率分别为 2 6 .6 7%、2 4 .2 4 %、35 .2 9% ;神经毒性发生率分别为 0、15 .15 %、0 ;三种方案间均无显著性差异 (P >0 .0 5 )。结论 :三种方案治疗晚期大肠癌的近期疗效无明显差别 ,毒副反应发生率低 ,耐受好 。
Purpose:To compare the effect and toxicity of 5-FU/LV, L-OHP+5-FU/LV, CPT-11+5-FU/LV in advanced colorectal cancers.Methods:65 patients were entered into the study. All the regimens were repeated every 3 weeks. 5-FU/LV regimen was given as LV 200mg/d,iv 2h,d 1-5; 5-FU 500 mg/d, iv d 1-5. L-OHP+5-FU/LV regimen was given as L-OHP 130mg/m 2 iv d 1, and 5-FU/LV same to the above. CPT-11+5-FU/LV regimen was given as CPT-11 180mg /m 2 30min d 1 and 5-FU/LV same to the above. Results:The overall response rate was 13.33%, 21.21%, 11.76% respectively (P>0.05). The overall rate of nausea/vomiting was 40.00% ,39.39%,17.65% respectively(P>0.05); the rate of diarrhea was 13.33%,6.06%,29.41% respectively(P>0.05); the rate of bone marrow depression was 26.67% ,24.24%,35.29% respectively (P>0.05) and the rate of cold related dysesthesia was 0,15.15%,0 respectively (P>0.05).Conclusions:There was no difference in terms of both effect and toxicity among the three regimens. All of them were effective and could be well tolerated by advanced colorectal cancer patients.
出处
《中国癌症杂志》
CAS
CSCD
2004年第3期265-267,共3页
China Oncology
关键词
大肠癌
氟尿嘧啶
亚叶酸钙
草酸铂
依立替康
colorectal cancers
fluorouracil/leucovorin
oxaliplatin
irinotecan